Literature DB >> 25735738

Distribution of interstitial pneumonia: a new radiological predictor of 90-day mortality after resection of lung cancer.

Mariko Fukui1, Kenji Suzuki2, Shiaki Oh1, Takeshi Matsunaga1, Yoshikazu Miyasaka1, Izumi Kawagoe3, Kazuya Takamochi1.   

Abstract

BACKGROUND: Surgery for lung cancer complicated by idiopathic interstitial pneumonia (IIP) is associated with a high rate of postoperative mortality. Thus, preoperative predictors of surgical mortality are needed to aid in the selection of suitable surgical candidates.
METHODS: The subjects of this retrospective study were 1625 patients who underwent resection of primary lung cancer between 2000 and 2012, 203 (12.5 %) of whom were found to have IIPs. The following radiological findings were also evaluated: presence of honeycombing and the distribution (diffuse or localized) and extension (central extension or peripheral localized) of honeycombing or infiltration. We also investigated clinical factors and conducted multivariate analyses to identify the predictors of surgical mortality.
RESULTS: The 30- and 90-day mortality rates were 0.5 and 1.4 % overall and 1.6 and 6.4 % in the IIP patients, respectively. Multivariate analysis revealed that a preoperative pO2 < 70 mmHg (HR 15.3), diffuse distribution and central extension of interstitial pneumonia on computed tomography (HR 9.2), and operative blood loss (ml: HR 1.003) were significant predictors of 90-day mortality.
CONCLUSIONS: Diffuse distribution and central extension of IIPs, as well as preoperative hypoxia and operative blood loss, were significant predictors of 90-day mortality.

Entities:  

Keywords:  Acute exacerbation; Complications; Interstitial pneumonia; Surgery

Year:  2015        PMID: 25735738     DOI: 10.1007/s00595-015-1143-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

Review 1.  Acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Robert Hyzy; Steven Huang; Jeffrey Myers; Kevin Flaherty; Fernando Martinez
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

2.  Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.

Authors:  Yuichi Saito; Yasuyuki Kawai; Nobumasa Takahashi; Tomohiko Ikeya; Katsumi Murai; Yoshinori Kawabata; Eishin Hoshi
Journal:  Ann Thorac Surg       Date:  2011-09-23       Impact factor: 4.330

3.  The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer.

Authors:  Yoshimasa Mizuno; Hisashi Iwata; Koyo Shirahashi; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki; Hirofumi Takemura
Journal:  Eur J Cardiothorac Surg       Date:  2012-04-14       Impact factor: 4.191

4.  Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection.

Authors:  Motoki Yano; Hidefumi Sasaki; Satoru Moriyama; Yu Hikosaka; Keisuke Yokota; Susumu Kobayashi; Masaki Hara; Yoshitaka Fujii
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-24

5.  Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation.

Authors:  P Misthos; S Katsaragakis; N Milingos; S Kakaris; E Sepsas; K Athanassiadi; D Theodorou; I Skottis
Journal:  Eur J Cardiothorac Surg       Date:  2005-01-23       Impact factor: 4.191

6.  Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes.

Authors:  Masako Chiyo; Yasuo Sekine; Takekazu Iwata; Koichiro Tatsumi; Kazuhiro Yasufuku; Akira Iyoda; Mizuto Otsuji; Shigetoshi Yoshida; Kiyoshi Shibuya; Toshihiko Iizasa; Yukio Saitoh; Takehiko Fujisawa
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

7.  Risk factors for acute lung injury after thoracic surgery for lung cancer.

Authors:  Marc Licker; Marc de Perrot; Anastase Spiliopoulos; John Robert; John Diaper; Catherine Chevalley; Jean-Marie Tschopp
Journal:  Anesth Analg       Date:  2003-12       Impact factor: 5.108

8.  Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.

Authors:  Luca Voltolini; Stefano Bongiolatti; Luca Luzzi; Elena Bargagli; Antonella Fossi; Claudia Ghiribelli; Paola Rottoli; Giuseppe Gotti
Journal:  Eur J Cardiothorac Surg       Date:  2012-11-04       Impact factor: 4.191

9.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.

Authors:  Toshihiko Sato; Satoshi Teramukai; Haruhiko Kondo; Atsushi Watanabe; Masahito Ebina; Kazuma Kishi; Yoshitaka Fujii; Tetsuya Mitsudomi; Masahiro Yoshimura; Tomohiro Maniwa; Kenji Suzuki; Kazuhiko Kataoka; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

10.  Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?

Authors:  Atsushi Watanabe; Tetsuya Higami; Syunsuke Ohori; Tetsuya Koyanagi; Shinji Nakashima; Tohru Mawatari
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-24       Impact factor: 5.209

View more
  3 in total

Review 1.  SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Authors:  Hanbo Chen; Alexander V Louie
Journal:  Curr Treat Options Oncol       Date:  2016-06

2.  Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema.

Authors:  Takahiro Mimae; Kenji Suzuki; Masahiro Tsuboi; Norihiko Ikeda; Kazuya Takamochi; Keiju Aokage; Yoshihisa Shimada; Yoshihiro Miyata; Morihito Okada
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection.

Authors:  Weipeng Shao; Jingjing Huang; Hongxiang Feng; Hongliang Sun; Yanhong Ren; Xiaowei Wang; Zhenrong Zhang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.